Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment
| Status: | Recruiting |
|---|---|
| Conditions: | Skin Cancer, Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/17/2019 |
| Start Date: | February 18, 2019 |
| End Date: | December 31, 2021 |
| Contact: | The Ohio State University Comprehensive Cancer Center |
| Email: | OSUCCCClinicaltrials@osumc.edu |
| Phone: | 1-800-293-5066 |
Inhaled Essential Oil Effect on Common Quality of Life Concerns During Cancer Treatment
This single-blind, randomized controlled trial studies how well inhaled essential oils work
for common quality of life concerns in patients who are undergoing cancer treatment such as
chemotherapy, targeted therapy, and/or immunotherapy given through the vein (intravenously).
Aromatherapy using essential oils, such as ginger essential oil, German chamomile essential
oil, and bergamot essential oil, may improve quality of life issues such as nausea, anxiety,
loss of appetite, and fatigue in patients undergoing treatment for cancer.
for common quality of life concerns in patients who are undergoing cancer treatment such as
chemotherapy, targeted therapy, and/or immunotherapy given through the vein (intravenously).
Aromatherapy using essential oils, such as ginger essential oil, German chamomile essential
oil, and bergamot essential oil, may improve quality of life issues such as nausea, anxiety,
loss of appetite, and fatigue in patients undergoing treatment for cancer.
PRIMARY OBJECTIVES:
I. To determine if aromatherapy, specifically inhaled essential oil, is beneficial for side
effects related to cancer treatments involving chemotherapy, targeted therapy, and/or
immunotherapy administered intravenously.
II. To describe the effect of inhaled ginger essential oil, German chamomile essential oil,
and bergamot essential oil on nausea and anxiety of patients receiving chemotherapy, targeted
therapy, and/or immunotherapy administered intravenously.
III. To describe the effect of decreased levels of nausea and/or anxiety on levels of
appetite and/or fatigue.
IV. To evaluate the acceptability of using a personal inhalation bottle for inhalation of
essential oils.
OUTLINE: Patients are randomized to 1 of 4 groups.
GROUP I: Patients inhale 7 drops of bergamot essential oil using a personalized inhalation
bottle three times daily (TID) (morning, midday, and evening) for up to 7 days. Patients also
use a journal to document symptoms, time of inhalation, and medication use TID for up to 7
days.
GROUP II: Patients inhale 7 drops of chamomile essential oil and complete journal as in group
I.
GROUP III: Patients inhale 7 drops of ginger essential oil and complete journal as in group
I.
GROUP IV (CONTROL): Patients inhale 7 drops of almond essential oil and complete journal as
in group I.
I. To determine if aromatherapy, specifically inhaled essential oil, is beneficial for side
effects related to cancer treatments involving chemotherapy, targeted therapy, and/or
immunotherapy administered intravenously.
II. To describe the effect of inhaled ginger essential oil, German chamomile essential oil,
and bergamot essential oil on nausea and anxiety of patients receiving chemotherapy, targeted
therapy, and/or immunotherapy administered intravenously.
III. To describe the effect of decreased levels of nausea and/or anxiety on levels of
appetite and/or fatigue.
IV. To evaluate the acceptability of using a personal inhalation bottle for inhalation of
essential oils.
OUTLINE: Patients are randomized to 1 of 4 groups.
GROUP I: Patients inhale 7 drops of bergamot essential oil using a personalized inhalation
bottle three times daily (TID) (morning, midday, and evening) for up to 7 days. Patients also
use a journal to document symptoms, time of inhalation, and medication use TID for up to 7
days.
GROUP II: Patients inhale 7 drops of chamomile essential oil and complete journal as in group
I.
GROUP III: Patients inhale 7 drops of ginger essential oil and complete journal as in group
I.
GROUP IV (CONTROL): Patients inhale 7 drops of almond essential oil and complete journal as
in group I.
Inclusion Criteria:
- Gastrointestinal cancers, neuroendocrine cancer, or melanoma
- Receiving chemotherapy, targeted therapy, and/or immunotherapy
- Not naive to the treatment
- Must be able to read and write English
Exclusion Criteria:
- Allergies to ragweed, chrysanthemum, chamomile, ginger, bergamot, citrus fruits, tree
nuts, perfumes
- Asthma diagnosis
- Patients receiving only octreotide injections
- Patients receiving floxuridine (FUDR) via hepatic artery infusion (HAI) pump only
We found this trial at
1
site
Columbus, Ohio 43210
Principal Investigator: Amber Williams, MSN, RN, OCN
Phone: 614-293-8830
Click here to add this to my saved trials
